K-Ras is a frequently mutated oncogene in CRC; its diverse mutations promote the activation of the MAPK pathway and cause spontaneous tumor development [126], and the aberrant activation of the PI3K/Akt/mTOR pathway strongly attenuates the efficacy of MAPK suppression [127]. This evidence concerns the gene KRAS and colorectal carcinoma.